B-NHL

Clinical trials for B-NHL explained in plain language.

Never miss a new study

Get alerted when new B-NHL trials appear

Sign up with your email to follow new studies for B-NHL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

Engineered immune cells show promise against tough childhood cancers

Disease control Completed

This phase 1 trial tested a new therapy called CD22-CAR T cells in 134 children and young adults (ages 1-39) with B-cell leukemia or lymphoma that had not been cured by standard treatments. The therapy involves taking a patient's own white blood cells, modifying them in a lab to …

Matched conditions: B-NHL

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 27, 2026 12:24 UTC

B-NHL

Get alerted when new B-NHL trials appear

Engineered immune cells show promise against tough childhood cancers